BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28426850)

  • 21. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditional relative survival among long-term survivors of adolescent and young adult cancers.
    Anderson C; Smitherman AB; Nichols HB
    Cancer; 2018 Jul; 124(14):3037-3043. PubMed ID: 29742278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
    Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
    Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
    Donin N; Filson C; Drakaki A; Tan HJ; Castillo A; Kwan L; Litwin M; Chamie K
    Cancer; 2016 Oct; 122(19):3075-86. PubMed ID: 27377470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt.
    Sedeta E; Jemal A; Nisotel L; Sung H
    Cancer; 2024 Jun; 130(11):1952-1963. PubMed ID: 38244208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
    Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic medical conditions and late effects following non-Hodgkin lymphoma in HIV-uninfected and HIV-infected adolescents and young adults: a population-based study.
    Abrahão R; Li QW; Malogolowkin MH; Alvarez EM; Ribeiro RC; Wun T; Keegan THM
    Br J Haematol; 2020 Aug; 190(3):371-384. PubMed ID: 32080836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL; Jain KS; Morris LG
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
    Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study.
    Wang J; Du Y; Kang Y
    Int J Gynaecol Obstet; 2024 Jun; 165(3):1229-1236. PubMed ID: 38205842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults.
    Keegan THM; Abrahão R; Alvarez EM
    J Clin Oncol; 2024 Feb; 42(6):630-641. PubMed ID: 37883740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
    Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
    Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
    Jiang S; Zhen H; Jiang H
    Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
    Jia H; Li Q; Yuan J; Sun X; Wu Z
    Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of second primary malignancies and survival of adult patients with polycythemia vera: A United States population-based retrospective study.
    Khanal N; Giri S; Upadhyay S; Shostrom VK; Pathak R; Bhatt VR
    Leuk Lymphoma; 2016; 57(1):129-33. PubMed ID: 26159045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
    Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009.
    Aben KK; van Gaal C; van Gils NA; van der Graaf WT; Zielhuis GA
    Acta Oncol; 2012 Sep; 51(7):922-33. PubMed ID: 22934554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.